OW DOSE INTRAVENOUS KETAMINE AS A PREEMPTIVE ANALGESIC FOR POSTOPERATIVE PAIN MANAGEMENT

Not Applicable

Completed

• Conditions: Health Condition 1: O- Medical and SurgicalHealth Condition 2: O- Medical and SurgicalHealth Condition 3: null- Patients undergoing elective surgery under General Anaesthesia

• Registration Number: CTRI/2018/03/012595
• Lead Sponsor: Armed Forces Medical College

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2019-08-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 77

Inclusion Criteria

1. Age > 12 years

2. ASA Class I, II

Exclusion Criteria

1.Intraoperative or postoperative administration of spinal/epidural anaesthesia or any regional blocks

2.Any severe perioperative complications requiring post op ICU admission

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To assess the efficacy of preemptive administration of low dose intravenous ketamine (0.5mg/kg) in patients undergoing surgery under GA on <br/ ><br>a)Total consumption of opioids (i.e. Tramadol) in first 24 hours postoperatively <br/ ><br>b)Time taken to first demand of rescue analgesia with opioid (i.e. Tramadol) <br/ ><br>Timepoint: 1 hour, 6 hours, 12 hours and 24 hours

Secondary Outcome Measures

Name	Time	Method
a)To study the efficacy of preemptive administration of low dose intravenous ketamine on postoperative pain scores <br/ ><br>Timepoint: 1 hour, 6 hours, 12 hours and 24 hours